Academic Respiratory Physician @Charlies_Resp & @Resp_Health | Senior Lecturer @uwanews | #NewPI #COPD #Asthma š¦šŗ š²š¾
Joined December 2010
- Tweets 1,677
- Following 1,509
- Followers 1,016
- Likes 1,294
90 Photos and videos
Sanjay Ramakrishnan retweeted
29 Nov 2024
ABRA kadabra šŖ.. possibly a new drug for COPD š¤š¾
28 Nov 2024
Treating eosinophilic exacerbations of #asthma and #COPD with benralizumab (ABRA): a double-blind, double-dummy, active placebo-controlled randomised trial
Read open access here: thelancet.com/journals/lanreā¦
@MonaBafadhel @BTSrespiratory @SanjayResp
@kingsmedicine
1
1
2
729
Sanjay Ramakrishnan retweeted
29 Nov 2024
Hereās the study thatās been making the headlines.
Congratulations to all the team for delivering this challenging study.
Exciting times aheadā¦ š ā¬ļø
28 Nov 2024
Treating eosinophilic exacerbations of #asthma and #COPD with benralizumab (ABRA): a double-blind, double-dummy, active placebo-controlled randomised trial
Read open access here: thelancet.com/journals/lanreā¦
@MonaBafadhel @BTSrespiratory @SanjayResp
@kingsmedicine
1
19
54
5,070
šFor the first time in 50 years there is a new treatment that helps improve the management of asthma and chronic obstructive pulmonary disease attacks! @UWAresearch @Resp_Health @SanjayResp
uwa.au/awq4bm
1
3
5
790
Sanjay Ramakrishnan retweeted
28 Nov 2024
Breaking News! š A major breakthrough in asthma treatment! š« A trial managed by @OxfordRespTrial has discovered the first new treatment for asthma attacks in 50 years. This could revolutionize care for millions. @UniofOxford @NDMOxford #research bbc.co.uk/news/articles/cev9ā¦
8
9
622
Sanjay Ramakrishnan retweeted
28 Nov 2024
Biologics for exacerbations, game-changer!
28 Nov 2024
Treating eosinophilic exacerbations of #asthma and #COPD with benralizumab (ABRA): a double-blind, double-dummy, active placebo-controlled randomised trial
Read open access here: thelancet.com/journals/lanreā¦
@MonaBafadhel @BTSrespiratory @SanjayResp
@kingsmedicine
1
5
348
Sanjay Ramakrishnan retweeted
28 Nov 2024
Such an important study. In people with acute asthma and COPD with eosinophilia regimes containing benralizumab were superior to prednisone alone in reference treatment failure at 90 days
28 Nov 2024
Woohooo! Thank you for showcasing our work @LancetRespirMed
1
3
9
917
A new era in the treatment of acute exacerbations of #asthma and #COPD - The ABRA Trial. Clarus Leung and I highlight ABRA's importance as well as its limitations.
thelancet.com/journals/lanreā¦
1
13
35
2,787
Sanjay Ramakrishnan retweeted
28 Nov 2024
Asthma & COPD breakthrough! For 1st time in 50 yrs, a new treatment's been found. Dr Sanjay Ramakrishnan's (@SanjayResp) trial shows benralizumab injection reduces severe asthma & COPD attacks. resphealth.org.au/2024/11/neā¦
#AsthmaTreatment #COPD #RespiratoryHealth
1
4
17
406
28 Nov 2024
Woohooo! Thank you for showcasing our work @LancetRespirMed
28 Nov 2024
Treating eosinophilic exacerbations of #asthma and #COPD with benralizumab (ABRA): a double-blind, double-dummy, active placebo-controlled randomised trial
Read open access here: thelancet.com/journals/lanreā¦
@MonaBafadhel @BTSrespiratory @SanjayResp
@kingsmedicine
1
5
27
2,360
28 Nov 2024
Wow. ABRA was highlighted by @EricTopol Thank you!
So proud to see this out for everyone to read. Our patients with and asthma and COPD deserve the best.
@LancetRespirMed @MonaBafadhel
28 Nov 2024
Some very good news for people with asthma and COPD.
The first new treatment for acute attacks in over 50 yearsāa monoclonal antibody vs interleukin-5 receptor-Ī±āwith efficacy in a randomized trial
thelancet.com/journals/lanreā¦ @LancetRespirMed @SanjayResp @MonaBafadhel @kingsmedicine
1
6
24
1,728
28 Nov 2024
@BBCWorld highlighting the patient impact of the ABRA trial. Thank you to Alison and Geoff for their amazing support of this study
bbc.com/news/articles/cev937ā¦
1
3
5
414
Sanjay Ramakrishnan retweeted
20 Nov 2024
Today is #worldCODPday, started by @gold_copd. This years theme is "Know Your Lung Function" as #spirometry is important for diagnosis & monitoring lung health.
TSANZ members worked with @ACSQHC to develop the recent clinical standards on COPD.
shorturl.at/zAWod
3
10
896
Sanjay Ramakrishnan retweeted
2 Nov 2024
Our @Charlies_Resp experts stealing the show at the Airways 2024 meeting in Sydney (1/4)
1
1
229
Sanjay Ramakrishnan retweeted
14 Oct 2024
And you can work with a world class pleural service! Spread the word for our new CF/Bronchiectasis consultant position please.
13 Oct 2024
Are you a bronchiectasis nerd? Want to come live in a city with the best beaches in the world? Look no further. This is your dream job opportunity! @NMHS_WA
The @Resp_Health infrastructure will allow you to grow your research too! @tsanz_thoracic @BTSrespiratory @EuroRespSoc
3
16
1,604
13 Oct 2024
Are you a bronchiectasis nerd? Want to come live in a city with the best beaches in the world? Look no further. This is your dream job opportunity! @NMHS_WA
The @Resp_Health infrastructure will allow you to grow your research too! @tsanz_thoracic @BTSrespiratory @EuroRespSoc
13 Oct 2024
šØJOB OPPORTUNITY
@Charlies_Resp is looking for a new colleague with a sub specialist interest in CF and non-CF bronchiectasis. Come lead the state CF service. You will get to work at our collaborative unit with our amazing multi-professional team.
Ad š
search.jobs.wa.gov.au/page.pā¦
1
2
10
2,622
1 Oct 2024
šØšØBig news for people with severe #asthma in Australia today. The Pharmaceutical Benefits Scheme (PBS) has changed the eligibility criteria for asthma biologics today (October 1). (1/3)
1
6
15
1,210
1 Oct 2024
No more minimum cumulative oral corticosteroids dose. It was always so silly when patients had to take more oral steroids to get a medicine designed to reduce oral steroids harm.
This retrograde requirement is gone! (2/3)
1
3
227
1 Oct 2024
Huge win for patients due to the advocacy from @AsthmaAustralia @tsanz_thoracic @GSK @AstraZeneca @sanofi
The right treatment for the right patient now without unnecessary additional harm š (3/3)
1
3
238